James Bean - Researcher Profile | RDL Research Database

Publications

2 shown

Specific <i>EGFR</i> Mutations Predict Treatment Outcome of Stage IIIB/IV Patients With Chemotherapy-Naive Non–Small-Cell Lung Cancer Receiving First-Line Gefitinib Monotherapy

James Chih‐Hsin Yang , Chong‐Jen Yu , Jin‐Yuan Shih +12 more

Purpose To explore predictive factors for time to treatment failure (TTF) in chemotherapy-naive non–small-cell lung cancer (NSCLC) patients receiving gefitinib treatment. Patien...

2008 Journal of Clinical Oncology 240 citations

Acquired Resistance to Epidermal Growth Factor Receptor Kinase Inhibitors Associated with a Novel T854A Mutation in a Patient with <i>EGFR</i>-Mutant Lung Adenocarcinoma

James Bean , Gregory J. Riely , Marissa N. Balak +4 more

Abstract Purpose: Somatic mutations in the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene are associated with sensitivity of lung adenocarcinomas to ...

2008 Clinical Cancer Research 276 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 516
Institution: National Taiwan University Hospital

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0001-6733-5794

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.